Abstract
The ermE gene was cloned from Streptomyces erythraeus into Escherichia coli on a series of plasmids. When transcribed from the lac promoter, ermE conferred high-level resistance to erythromycin and other macrolide-lincosamide-streptogramin-B (MLS) antibiotics. A methylase activity capable of N6-mono- and N6,N6 dimethylation of adenine residues in E. coli rRNA was detected in extracts of MLS-resistant cells. In addition, rRNA extracted from MLS-resistant E. coli contained N6-mono- and N6,N6-dimethylated adenine residues.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 319-325 |
| Number of pages | 7 |
| Journal | Gene |
| Volume | 55 |
| Issue number | 2-3 |
| DOIs | |
| State | Published - 1987 |
Keywords
- Recombinant DNA
- adenine methylation
- erythromycin resistance
- heterologous gene expression
- in vitro assay
- phage γ vector
Fingerprint
Dive into the research topics of 'Expression of the macrolide-lincosamide-streptogramin-B-resistance methylase gene, ermE, from Streptomyces erythraeus in Escherichia coli results in N6-monomethylation and N6,N6-dimethylation of ribosomal RNA'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS